Neurología Cognitiva: Recent submissions

  • Clinical Manifestations 
    Clarens, María Florencia; Chrem Méndez, Patricio Alexis; Tapajoz, Fernanda; Martinez, Carlos; Helou, María Belén; Surace, Ezequiel Ignacio; Crivelli, Lucía; Romero, Daniela; Vigo, Gabriela; Allegri, Ricardo Francisco (Wiley, 2023-12-25)
    Background: In recent years, there has been an increase in the number of case reports of families with autosomal dominant Alzheimer's disease (ADAD) in Latin America (LA). Nevertheless, little is known about the clinical ...
  • Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease: The DIAN-TU-001 Randomized Clinical Trial 
    Wagemann, Olivia; Liu, Haiyan; Wang, Guoqiao; Shi, Xinyu; Bittner, Tobias; Scelsi, Marzia A.; Farlow, Martin R.; Clifford, David B.; Supnet Bell, Charlene; Santacruz, Anna M.; Aschenbrenner, Andrew J.; Hassenstab, Jason J.; Benzinger, Tammie L.S.; Gordon, Brian A.; Coalier, Kelley A.; Cruchaga, Carlos; Ibanez, Laura; Perrin, Richard J.; Xiong, Chengjie; Li, Yan; Morris, John C.; Lah, James J.; Berman, Sarah B.; Roberson, Erik D.; van Dyck, Christopher H.; Galasko, Douglas; Gauthier, Serge; Hsiung, Ging-Yuek R.; Brooks, William S.; Pariente, Jérémie; Mummery, Catherine J.; Day, Gregory S.; Ringman, John M.; Chrem Méndez, Patricio Alexis; Dominantly Inherited Alzheimer Network–Trials Unit (American Medical Association, 2024-06-01)
    Importance: Effects of antiamyloid agents, targeting either fibrillar or soluble monomeric amyloid peptides, on downstream biomarkers in cerebrospinal fluid (CSF) and plasma are largely unknown in dominantly inherited ...
  • Advancements in dementia research, diagnostics, and care in Latin America: Highlights from the 2023 Alzheimer's Association International conference satellite symposium in Mexico City 
    Sosa, Ana Luisa; Brucki, Sonia M.; Crivelli, Lucía; Lopera, Francisco Javier; Acosta, Daisy M.; Acosta Uribe, Juliana; Aguilar, Diego; Aguilar Navarro, Sara G.; Allegri, Ricardo Francisco; Bertolucci, Paulo H.; Calandri, Ismael Luis; Carrillo, María C.; Chrem Méndez, Patricio Alexis; Cornejo Olivas, Mario; Custodio, Nilton; Damián, Andrés; Cruz de Souza, Leonardo; Duran Aniotz, Claudia; García, Adolfo M.; Sevlever, Gustavo Emilio (John Wiley & Sons, 2024-05-27)
    Introduction: While Latin America (LatAm) is facing an increasing burden of dementia due to the rapid aging of the population, it remains underrepresented in dementia research, diagnostics, and care. Methods: In 2023, ...
  • Generating real-world evidence in Alzheimer's disease: Considerations for establishing a core dataset 
    Galvin, James E.; Cummings, Jeffrey L.; Levitchi Benea, Mihaela; de Moor, Carl; Allegri, Ricardo Francisco; Atri, Alireza; Chertkow, Howard; Paquet, Claire; Porter, Verna R.; Ritchie, Craig W.; Sikkes, Sikkes A.M.; Smith, Michael R.; Grassi, Christina Marsica; Rubino, Ivana (John Wiley & Sons, Ltd., 2024-05-06)
    Ongoing assessment of patients with Alzheimer's disease (AD) in postapproval studies is important for mapping disease progression and evaluating real-world treatment effectiveness and safety. However, interpreting outcomes ...
  • The impact of reward and punishment sensitivity on memory and executive performance in individuals with amnestic mild cognitive impairment 
    Corvalán, Nicolás; Crivelli, Lucía; Allegri, Ricardo Francisco; Pedreira, Maria E.; Fernández, Rodrigo S. (Elsevier/North-Holland Biomedical Pres, 2024-06-10)
    Amnestic mild cognitive impairment (aMCI) is defined by memory impairment but executive function (EF) deficits could be also a common feature. This study examined the underlying neurocognitive processes associated with ...
  • Qué es un banco de cerebros 
    Sevlever, Gustavo Emilio (Polemos, 2023)
    Capítulo 17 de "Enfermedad de Alzheimer y otras demencias: manual para la familia"
  • Difundir la prevención a la comunidad: llegar antes 
    Canevaro, Lilia; Bagnati, Pablo M. (Polemos, 2023)
    Capítulo 14 de "Enfermedad de Alzheimer y otras demencias: manual para la familia"
  • Tratamientos en demencias 
    Bagnati, Pablo M.; Kremer, Janus; Waisman Campos, Marcela (Polemos, 2023)
    Capítulo 12 de "Enfermedad de Alzheimer y otras demencias: manual para la familia"
  • Conducción de automóviles y demencia 
    Bagnati, Pablo M.; Sambade, Silvia (Polemos, 2023)
    Capítulo 11 de "Enfermedad de Alzheimer y otras demencias: manual para la familia"
  • ¿Por qué muere un paciente con Alzheimer? Complicaciones médicas y neurológicas en la progresión de la demencia 
    Cohen, Gabriela; Campos, Jorge (Polemos, 2023)
    Capítulo 10 de "Enfermedad de Alzheimer y otras demencias: manual para la familia"
  • ¿Qué riesgo tengo de heredar la enfermedad de Alzheimer? Genética y demencias 
    Chrem Méndez, Patricio Alexis; Surace, Ezequiel Ignacio (Polemos, 2023)
    Capítulo 7 de "Enfermedad de Alzheimer y otras demencias: manual para la familia"
  • ¿Qué es la demencia? 
    Bagnati, Pablo M. (Polemos, 2023)
    Introducción de "Enfermedad de Alzheimer y otras demencias: manual para la familia"
  • Trastornos de conducta en la enfermedad de Alzheimer 
    Magrath Guimet, Nahuel; Herrera, Julio José; Fernández, María Laura (Polemos, 2023)
    Capítulo 4 de "Enfermedad de Alzheimer y otras demencias: manual para la familia"
  • Olvidos: ¿normal envejecimiento o síntomas de enfermedad? 
    Castro, Diego M.; Allegri, Ricardo Francisco (Polemos, 2023)
    Capítulo 2 de "Enfermedad de Alzheimer y otras demencias: manual para la familia"
  • Enfermedad de Alzheimer y otras demencias : manual para la familia 
    Bagnati, Pablo M. (Polemos, 2023)
    Resumen no disponible
  • Molecular neuroimaging in dominantly inherited versus sporadic early-onset Alzheimer's disease. 
    Iaccarino, Leonardo; Llibre Guerra, Jorge J.; McDade, Eric; Edwards, Lauren; Gordon, Brian A.; Benzinger, Tammie L.S.; Hassenstab, Jason; Kramer, Joel H.; Li, Yan; Miller, Bruce L.; Miller, Zachary; Morris, John C.; Mundada, Nidhi; Perrin, Richard J.; Rosen, Howard J.; Soleimani Meigooni, David; Strom, Amelia; Tsoy, Elena; Wang, Guoqiao; Xiong, Chengjie; Allegri, Ricardo Francisco; Chrem Méndez, Patricio Alexis; Vázquez, Silvia (Oxford University Press, 2024-05-03)
    Approximately 5% of Alzheimer's disease patients develop symptoms before age 65 (early-onset Alzheimer's disease), with either sporadic (sporadic early-onset Alzheimer's disease) or dominantly inherited (dominantly inherited ...
  • Decentralized clinical trials for medications to reduce the risk of dementia: Consensus report and guidance 
    Howard, Leanne; Abdelnour, Carla; Abner, Erin L.; Allegri, Ricardo Francisco; Dodge, Hiroko H.; Gauthier, Serge; Hoyos, Camilla M.; Jicha, Gregory A.; Kehoe, Patrick G.; Mummery, Catherine J.; Ogunniyi, Adesola; Scarmeas, Nikolaos; Chen, Xiaoying; Titiner, Jodie R.; Weber, Christopher R.; Clinical Trial Methodology Working review group members; Peters, Ruth (John Wiley & Sons, 2024-06-02)
    Introduction: Recent growth in the functionality and use of technology has prompted an increased interest in the potential for remote or decentralized clinical trials in dementia. There are many potential benefits associated ...
  • Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional study 
    Wisch, Julie K.; McKay, Nicole S.; Boerwinkle, Anna H.; Kennedy, James; Flores, Shaney; Handen, Benjamin L.; Christian, Bradley T.; Head, Elizabeth; Mapstone, Mark; Rafii, Michael S.; O'Bryant, Sid E.; Price, Julie C.; Laymon, Charles M.; Krinsky-McHale, Sharon J.; Lai, Florence; Alzheimer's Biomarker Consortium-Down Syndrome; Dominantly Inherited Alzheimer Network; Allegri, Ricardo Francisco; Chrem Méndez, Patricio Alexis; Surace, Ezequiel Ignacio (Lancet Pub. Group, 2024-05)
    Background: In people with genetic forms of Alzheimer's disease, such as in Down syndrome and autosomal-dominant Alzheimer's disease, pathological changes specific to Alzheimer's disease (ie, accumulation of amyloid and ...
  • α-Synuclein seed amplification assay detects Lewy body co-pathology in autosomal dominant Alzheimer's disease late in the disease course and dependent on Lewy pathology burden 
    Levin, Johannes; Baiardi, Simone; Quadalti, Corinne; Rossi, Marcello; Mammana, Angela; Vöglein, Jonathan; Bernhardt, Alexander; Perrin, Richard J.; Jucker, Mathias; Preische, Oliver; Hofmann, Anna; Höglinger, Günter U.; Cairns, Nigel; Franklin, Erin E.; Chrem Méndez, Patricio Alexis; Dominantly Inherited Alzheimer Network (John Wiley & Sons, 2024-04-26)
    Introduction: Amyloid beta and tau pathology are the hallmarks of sporadic Alzheimer's disease (AD) and autosomal dominant AD (ADAD). However, Lewy body pathology (LBP) is found in ≈ 50% of AD and ADAD brains. Methods: ...
  • Cognitive Rehabilitation Using Teleneuropsychology. A Cohort Study in South America 
    Martínez Canyazo, Carlos; Fernández, Rodrigo Sebastián; Helou, María Belén; Arruabarrena, Micaela María; Corvalán, Nicolás; Carello, María Agostina; Harris, Paula; Feldman, Mónica; Calandri, Ismael Luis; Martin, María Eugenia; Allegri, Ricardo Francisco; Crivelli, Lucía (Cambridge University Press, 2023-12-21)
    Objective: The COVID-19 pandemic has affected the continuity of cognitive rehabilitation (CR) worldwide. However, the use of teleneuropsychology (TNP) to provide CR has contributed significantly to the continuity of ...

Search DSpace


Browse

My Account